메뉴 건너뛰기
JAMA
Volumn 296, Issue 19, 2006, Pages 2371-2373
PSA testing: Public policy or private penchant?
Author keywords

[No Author keywords available]
Indexed keywords

PROSTATE SPECIFIC ANTIGEN;
EID: 33750976170     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.19.2371     Document Type: Editorial
Times cited : (13)
References (22)
  • 1
    • 33750978664 scopus 로고    scopus 로고
    • PSA screening among elderly men with limited life expectancies
    • Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296:2336-2442.
    • (2006) JAMA , vol.296 , pp. 2336-2442
    • Walter, L.C.1    Bertenthal, D.2    Lindquist, K.3    Konety, B.R.4
  • 2
    • 0023789114 scopus 로고
    • Cancer screening: Degrees of proof and practical application
    • Hulka BS. Cancer screening: degrees of proof and practical application. Cancer. 1988;62(8 suppl):1776-1780.
    • (1988) Cancer , vol.62 , Issue.8 SUPPL. , pp. 1776-1780
    • Hulka, B.S.1
  • 4
    • 0027989441 scopus 로고
    • Prostate specific antigen and prostate specific antigen density: Roles in patient evaluation and management
    • Benson MC, Olsson CA. Prostate specific antigen and prostate specific antigen density: roles in patient evaluation and management. Cancer. 1994;74:1667-1673.
    • (1994) Cancer , vol.74 , pp. 1667-1673
    • Benson, M.C.1    Olsson, C.A.2
  • 5
    • 0028800933 scopus 로고
    • Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
    • Catalona WJ, Smith DS, Wolfert RL, et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA. 1995;274:1214-1220.
    • (1995) JAMA , vol.274 , pp. 1214-1220
    • Catalona, W.J.1    Smith, D.S.2    Wolfert, R.L.3
  • 6
    • 0027244140 scopus 로고
    • Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges
    • Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA. 1993;270:860-864.
    • (1993) JAMA , vol.270 , pp. 860-864
    • Oesterling, J.E.1    Jacobsen, S.J.2    Chute, C.G.3
  • 7
    • 1242287573 scopus 로고    scopus 로고
    • Winners and losers
    • Merenstein D. Winners and losers. JAMA. 2004;291:15-16.
    • (2004) JAMA , vol.291 , pp. 15-16
    • Merenstein, D.1
  • 8
    • 2642548279 scopus 로고    scopus 로고
    • Natural history of early, localized prostate cancer
    • Johansson JE, Andren O, Andersson SO, et al. Natural history of early, localized prostate cancer. JAMA. 2004;291:2713-2719.
    • (2004) JAMA , vol.291 , pp. 2713-2719
    • Johansson, J.E.1    Andren, O.2    Andersson, S.O.3
  • 9
    • 17844402699 scopus 로고    scopus 로고
    • 20-Year outcomes following conservative management of clinically localized prostate cancer
    • Albertsen PC, Hanley JA, Fine J. 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293:2095-2101.
    • (2005) JAMA , vol.293 , pp. 2095-2101
    • Albertsen, P.C.1    Hanley, J.A.2    Fine, J.3
  • 10
    • 21044453581 scopus 로고    scopus 로고
    • Radical prostatectomy versus watchful waiting in early prostate cancer
    • Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977-1984.
    • (2005) N Engl J Med , vol.352 , pp. 1977-1984
    • Bill-Axelson, A.1    Holmberg, L.2    Ruutu, M.3
  • 11
    • 0038205813 scopus 로고    scopus 로고
    • Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
    • D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol. 2003;21:2163-2172.
    • (2003) J Clin Oncol , vol.21 , pp. 2163-2172
    • D'Amico, A.V.1    Moul, J.2    Carroll, P.R.3    Sun, L.4    Lubeck, D.5    Chen, M.H.6
  • 12
    • 0034685027 scopus 로고    scopus 로고
    • Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study
    • Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000;283:354-360.
    • (2000) JAMA , vol.283 , pp. 354-360
    • Stanford, J.L.1    Feng, Z.2    Hamilton, A.S.3
  • 13
    • 0035340183 scopus 로고    scopus 로고
    • Health outcomes after externalbeam radiation therapy for clinically localized prostate cancer: Results from the Prostate Cancer Outcomes Study
    • Hamilton AS, Stanford JL, Gilliland FD, et al. Health outcomes after externalbeam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol. 2001;19:2517-2526.
    • (2001) J Clin Oncol , vol.19 , pp. 2517-2526
    • Hamilton, A.S.1    Stanford, J.L.2    Gilliland, F.D.3
  • 14
    • 0037068634 scopus 로고    scopus 로고
    • Quality of life after radical prostatectomy or watchful waiting
    • Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347:790-796.
    • (2002) N Engl J Med , vol.347 , pp. 790-796
    • Steineck, G.1    Helgesen, F.2    Adolfsson, J.3
  • 15
    • 0026522840 scopus 로고
    • Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease
    • Carter HB, Pearson JD, Metter EJ, et al. Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. JAMA. 1992;267:2215-2220.
    • (1992) JAMA , vol.267 , pp. 2215-2220
    • Carter, H.B.1    Pearson, J.D.2    Metter, E.J.3
  • 16
    • 3042727071 scopus 로고    scopus 로고
    • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    • D'Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004;351:125-135.
    • (2004) N Engl J Med , vol.351 , pp. 125-135
    • D'Amico, A.V.1    Chen, M.H.2    Roehl, K.A.3    Catalona, W.J.4
  • 17
    • 0038275923 scopus 로고    scopus 로고
    • Lead times and overdetection due to prostate-specific antigen screening: Estimates from the European Randomized Study of Screening for Prostate Cancer
    • Draisma G, Boer R, Otto SJ, et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst. 2003;95:868-878.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 868-878
    • Draisma, G.1    Boer, R.2    Otto, S.J.3
  • 19
    • 0034125690 scopus 로고    scopus 로고
    • Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy
    • Epstein JI. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy. Am J Surg Pathol. 2000;24:477-478.
    • (2000) Am J Surg Pathol , vol.24 , pp. 477-478
    • Epstein, J.I.1
  • 20
    • 0037049994 scopus 로고    scopus 로고
    • Large-scale randomized prostate cancer screening trials: Program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial
    • de Koning HJ, Auvinen A, Berenguer Sanchez A, et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer. 2002;97:237-244.
    • (2002) Int J Cancer , vol.97 , pp. 237-244
    • De Koning, H.J.1    Auvinen, A.2    Berenguer Sanchez, A.3
  • 21
    • 0034572611 scopus 로고    scopus 로고
    • Prostate, lung, colorectal and ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status
    • Gohagan JK, Prorok PC, Hayes RB, Kramer BS. Prostate, lung, colorectal and ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials. 2000;21(suppl 6):251S-272S.
    • (2000) Control Clin Trials , vol.21 , Issue.SUPPL. 6
    • Gohagan, J.K.1    Prorok, P.C.2    Hayes, R.B.3    Kramer, B.S.4
  • 22
    • 0037015999 scopus 로고    scopus 로고
    • Screening for prostate cancer: Recommendation and rationale
    • US Preventive Services Task Force
    • US Preventive Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002;137:915-916.
    • (2002) Ann Intern Med , vol.137 , pp. 915-916

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.